Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05409131 · ClinicalTrials.gov registry record · NA
Omnipod 5 System Compared to Pump Therapy
A NA study, sponsored by Insulet Corporation.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
NCT05409131 is a NA study that has completed, run by Insulet Corporation. The registered enrollment target is 196 participants.
The verdict
NCT05409131, a NA study, has completed, sponsored by Insulet Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
Study Summary
Subject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the study provided continuous glucose monitoring system. Participants in France will be offered an optional extension of 12 months of Omnipod 5 System use.
Interventions
- DEVICE Omnipod 5 System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2022-07-07 |
| Est. Completion | 2025-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05409131
The ClinicalTrials.gov registry entry for NCT05409131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Insulet Corporation, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Omnipod 5 System is the first listed.
NCT05409131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05409131 about?
NCT05409131 is a clinical study titled "Omnipod 5 System Compared to Pump Therapy". Subject will undergo a 14-day outpatient, standard therapy phase during which sensor and insulin data will be collected. This will be followed by a 90-day outpatient phase where subjects will either use the Omnipod 5 system or continue to use their personal insulin pump with the study provided conti...
What is the current status of trial NCT05409131?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2022-07-07. Estimated completion is 2025-01-10.
What interventions are being tested in trial NCT05409131?
The interventions under investigation include: Omnipod 5 System (DEVICE).
Who is sponsoring clinical trial NCT05409131?
This trial is sponsored by Insulet Corporation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.